Dr. Lupe Salazar of the Seattle Cancer Care Alliance has received a University of Washington General Clinical Research Center (GCRC) 2006 Pilot and Feasibility Grant.
Salazar, who is also acting instructor, Department of Medicine, UW, Division of Oncology, is conducting a Phase I dose-escalation study of ONTAK, a cytoxic-fusion protein that may help treat patients with advanced ovarian cancer.
Funded by the National Institutes of Health, the GCRC supports peer-reviewed clinical investigations or other funded research involving human subjects. The GCRC's Pilot and Feasibility Grant program helps junior investigators by facilitating career development in clinical research.
Each year, the GCRC seeks applications for well-defined projects that will use GCRC resources. The grants are open to investigators early in their careers or established investigators proposing a new direction in their clinical research.
Based on available funding, the GCRC supports up to three pilot projects at a maximum budget of $25,000 each (one adult award, one pediatric-unit award and one biotherapeutics award). This year, due to the availability of extra non-federal funds, the GCRC awarded a total of five grants.
To learn more and to read abstracts from the 2006 awardees, visit www.crc.washington.edu/About/PilotAwards2006.aspx.